These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 649987)

  • 21. Eikenella corrodens endocarditis: report of cure in two cases.
    Geraci JE; Hermans PE; Washington JA
    Mayo Clin Proc; 1974 Dec; 49(12):950-3. PubMed ID: 4444342
    [No Abstract]   [Full Text] [Related]  

  • 22. Antimicrobial drugs for anaerobic bacterial infections.
    Med Lett Drugs Ther; 1972 Nov; 14(23):88. PubMed ID: 4648570
    [No Abstract]   [Full Text] [Related]  

  • 23. [In vitro and in vivo antimicrobial activities of cefmetazole against Bacteroides fragilis].
    Isono M; Kawashima K; Yamada N; Aoki M; Kobayashi T; Sawa K; Watanabe K; Ueno K
    Jpn J Antibiot; 1982 Jul; 35(7):1667-72. PubMed ID: 6757469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mismanaged facial infection.
    Webb CH
    Lancet; 1977 Sep; 2(8036):511. PubMed ID: 70724
    [No Abstract]   [Full Text] [Related]  

  • 25. [Restudies on antibacterial activity of sulbenicillin against anaerobic bacteria (author's transl)].
    Umemura A; Isono M; Yamada N; Kobayashi T; Watanabe K; Ueno K
    Jpn J Antibiot; 1981 Jun; 34(6):976-9. PubMed ID: 7026824
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bacteriological and clinical studies on metronidazole in Bacteroides fragilis infections (author's transl)].
    Shimada K; Inamatsu T; Sato K
    Jpn J Antibiot; 1979 Feb; 32(2):191-4. PubMed ID: 439390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bone and suppurative lesion distribution of antimicrobial agents (ampicillin and ofloxacin) in experimental infected rabbits].
    Sugimoto R; Satoh T
    Shigaku; 1989 Apr; 76(7):1527-55. PubMed ID: 2761966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
    Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
    Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.
    Brook I
    Surg Gynecol Obstet; 1987 Dec; 165(6):491-5. PubMed ID: 3317944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotics can prevent implant failure.
    J Am Dent Assoc; 1994 May; 125(5):508. PubMed ID: 8195490
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic efficacy and pharmacokinetic properties of ciprofloxacin in intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.
    Fu KP; Vince T; Bloom R; Gregory FJ; Hung PP
    Drugs Exp Clin Res; 1987; 13(8):493-6. PubMed ID: 3322752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of aspiration pneumonia and primary lung abscess. Penicillin G vs clindamycin.
    Bartlett JG; Gorbach SL
    JAMA; 1975 Dec; 234(9):935-7. PubMed ID: 1041750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Bacteroides fragilis cell envelope: quarterback, linebacker, coach-or all three?
    Pumbwe L; Skilbeck CA; Wexler HM
    Anaerobe; 2006; 12(5-6):211-20. PubMed ID: 17045496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on suppurative lesion and bone distribution of peroral antimicrobial agents (LAPC and TFLX) to experimental infected rabbits].
    Tanaka M; Satoh T
    Shigaku; 1990 Oct; 78(3):527-52. PubMed ID: 2134803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study in vitro of the sensitivity to antibiotics of Bacteroides fragilis.
    Ingham HR; Selkon JB; Codd AA; Hale JH
    J Clin Pathol; 1968 Jul; 21(4):432-6. PubMed ID: 4301500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro bactericidal activities and morphologic changes in Escherichia coli and Bacteroides fragilis by cephalosporins.
    Mikamo H; Kawazoe K; Sato Y; Hayasaki Y; Satoh M; Kai J; Tamaya T
    Chemotherapy; 1998; 44(3):157-63. PubMed ID: 9612605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli.
    Schaumann R; Blatz R; Beer J; Ackermann G; Rodloff AC
    J Antimicrob Chemother; 2004 Feb; 53(2):318-24. PubMed ID: 14729746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimentally induced Bacteroides infections in the rabbit.
    Salt WG; Samara MA; Stretton RJ
    Microbios; 1987; 50(204-205):163-75. PubMed ID: 3112527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice.
    Dijkmans BA; Vaishnav J; Mattie H
    Chemotherapy; 1985; 31(4):297-303. PubMed ID: 4028873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Migration of rat peritoneal cells after intra-abdominal infection with Bacteroides fragilis and Escherichia coli.
    Verweij WR; Namavar F; Schouten WF; de Graaff J; MacLaren DM
    J Gen Microbiol; 1993 Aug; 139(8):1739-44. PubMed ID: 8409916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.